SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (7549)12/19/2002 10:16:26 AM
From: quidditch  Read Replies (1) | Respond to of 52153
 
Peter, actually GS did put out that assessment Tuesday morning, before the actions of the AC and any movement by IDPH or CRXA. The summary of its analysis was posted:

Message 18340397

quid



To: Biomaven who wrote (7549)12/19/2002 10:53:51 AM
From: Sam Citron  Read Replies (1) | Respond to of 52153
 
Peter,

Are you warming to CRXA now that Bex has ODAC approval (as you expected) and lower prices?

Do you happen to have sales figures for Rit and Zev? Agree it's nice to have GSK's help educating the market.

Sam


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News